|
1
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: a fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baylin S: DNA methylation and epigenetic
mechanisms of carcinogenesis. Dev Biol. 106:85–87. 2001.PubMed/NCBI
|
|
3
|
Yang X, Yan L and Davidson NE: DNA
methylation in breast cancer. Endocr Relat Cancer. 8:115–127. 2001.
View Article : Google Scholar
|
|
4
|
Lapidus RG, Ferguson AT, Ottaviano YL,
Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JP and Davidson NE:
Methylation of estrogen and progesterone receptor gene 5′ CpG
islands correlates with lack of estrogen and progesterone receptor
gene expression in breast tumors. Clin Cancer Res. 2:805–810.
1996.
|
|
5
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: a booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esteller M: Dormant hypermethylated tumour
suppressor genes: questions and answers. J Pathol. 205:172–180.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanai Y and Hirohashi S: Alterations of
DNA methylation associated with abnormalities of DNA
methyltransferases in human cancers during transition from a
precancerous to a malignant state. Carcinogenesis. 28:2434–2442.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewis CM, Cler LR, Bu DW, Zochbauer-Muller
S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD and Euhus DM:
Promoter hypermethylation in benign breast epithelium in relation
to predicted breast cancer risk. Clin Cancer Res. 11:166–172.
2005.PubMed/NCBI
|
|
9
|
Ai L, Kim WJ, Kim TY, Fields CR, Massoll
NA, Robertson KD and Brown KD: Epigenetic silencing of the tumor
suppressor cystatin M occurs during breast cancer progression.
Cancer Res. 66:7899–7909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roll JD, Rivenbark AG, Jones WD and
Coleman WB: DNMT3b overexpression contributes to a hypermethylator
phenotype in human breast cancer cell lines. Mol Cancer. 7:152008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Robertson KD, Uzvolgyi E, Liang G,
Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA
methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression
in normal tissues and overexpression in tumors. Nucleic Acids Res.
27:2291–2298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Girault I, Tozlu S, Lidereau R and Bieche
I: Expression analysis of DNA methyltransferases 1, 3A and 3B in
sporadic breast carcinomas. Clin Cancer Res. 9:4415–4422.
2003.PubMed/NCBI
|
|
13
|
Mizuno S, Chijiwa T, Okamura T, Akashi K,
Fukumaki Y, Niho Y and Sasaki H: Expression of DNA
methyltransferases DNMT1, 3A and 3B in normal hematopoiesis and in
acute and chronic myelogenous leukemia. Blood. 97:1172–1179. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin F, Dowdy SC, Xiong Y, Eberhardt NL,
Podratz KC and Jiang SW: Up-regulation of DNA methyltransferase 3B
expression in endometrial cancers. Gynecol Oncol. 96:531–538. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Veeck J and Esteller M: Breast cancer
epigenetics: from DNA methylation to microRNAs. J Mammary Gland
Biol Neoplasia. 15:5–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel B: MicroRNAs directing siRNA
biogenesis. Nat Struct Mol Biol. 12:569–571. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sevignani C, Calin GA, Siracusa LD and
Croce CM: Mammalian microRNAs: a small world for fine-tuning gene
expression. Mamm Genome. 17:189–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Geneτ Dev.
15:563–568. 2005.PubMed/NCBI
|
|
20
|
Carleton M, Cleary MA and Linsley PS:
MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Rai K, et al: Frequent deletions and down-regulation of micro-RNA
genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.
Proc Natl Acad Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, et al: MicroRNA gene expression deregulation in human
breast cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lujambio A, Calin GA, Villanueva A, Ropero
S, Sanchez-Cespedes M, et al: A microRNA DNA methylation signature
for human cancer metastasis. Proc Natl Acad Sci USA.
105:13556–13561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, et al: MicroRNA-29 family reverts aberrant methylation in
lung cancer by targeting DNA methyltransferases 3A and 3B. Proc
Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Garzon R, Liu S, Fabbri M, Liu Z, Heaphy
CE, et al: MicroRNA-29b induces global DNA hypomethylation and
tumor suppressor gene reexpression in acute myeloid leukemia by
targeting directly DNMT3A and 3B and indirectly DNMT1. Blood.
113:6411–6418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duursma AM, Kedde M, Schrier M, Le Sage C
and Agami R: miR-148 targets human DNMT3b protein coding region.
RNA. 14:872–877. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saito Y, Liang G, Egger G, Friedman JM,
Chuang JC, Coetzee GA and Jones PA: Specific activation of
microRNA-127 with down-regulation of the proto-oncogene BCL6 by
chromatin-modifying drugs in human cancer cells. Cancer Cell.
9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gaur A, Jewell DA, Liang Y, Ridzon D,
Moore JH, Chen C, Ambros VR and Israel MA: Characterization of
microRNA expression levels and their biological correlates in human
cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sandhu R, Rivenbark AG and Coleman WB:
Enhancement of chemotherapeutic efficacy in hypermethylator breast
cancer cells through targeted and pharmacologic inhibition of
DNMT3b. Breast Cancer Res Treatment. 131:385–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, et al: A microRNA signature associated with prognosis
and progression in chronic lymphocytic leukemia. N Engl J Med.
353:1793–1801. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nikiforova MN, Tseng GC, Steward D, Diorio
D and Nikiforov YE: MicroRNA expression profiling of thyroid
tumors: biological significance and diagnostic utility. J Clin
Endocrinol Metab. 93:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev. 4:143–153. 2004. View Article : Google Scholar
|
|
36
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
37
|
Toyota M, Ahuja N, Ohe-Toyota M, Herman
JG, Baylin SB and Issa JP: CpG island methylator phenotype in
colorectal cancer. Proc Natl Acad Sci USA. 96:8681–8686. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen L, Ahuja N, Shen Y, Habib NA, Toyota
M, Rashid A and Issa JP: DNA methylation and environmental
exposures in human hepatocellular carcinoma. J Natl Cancer Inst.
94:755–761. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toyota M, Ahuja N, Suzuki H, Itoh F,
Ohe-Toyota M, Imai K, Baylin SB and Issa JP: Aberrant methylation
in gastric cancer associated with the CpG island methylator
phenotype. Cancer Res. 59:5438–5442. 1999.PubMed/NCBI
|
|
40
|
Diaz LK, Cryns VL, Symmans WF and Sneige
N: Triple negative breast carcinoma and the basal phenotype: from
expression profiling to clinical practice. Adv Anat Pathol.
14:419–430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Korsching E, Jeffrey SS, Meinerz W, Decker
T, Boecker W and Buerger H: Basal carcinoma of the breast
revisited: an old entity with new interpretations. J Clin Pathol.
61:553–560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Duffy MJ: Estrogen receptors: role in
breast cancer. Crit Rev Clin Lab Sci. 43:325–347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Slamon D and Pegram M: Rationale for
trastuzumab (Herceptin) in adjuvant breast cancer trials. Semin
Oncol. 28:13–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Visone R and Croce CM: miRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar
|
|
46
|
Wang Y and Lee CG: MicroRNA and
cancer-focus on apoptosis. J Cell Mol Med. 13:12–23. 2009.
View Article : Google Scholar
|
|
47
|
Sengupta S, den Boon JA, Chen IH, Newton
MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B and
Ahlquist P: MicroRNA 29c is down-regulated in nasopharyngeal
carcinomas, up-regulating mRNAs encoding extracellular matrix
proteins. Proc Natl Acad Sci USA. 105:5874–5878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
49
|
Bueno MJ, Perez de Castro I, Gomez de
Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM,
Fernandez-Piqueras J and Malumbres M: Genetic and epigenetic
silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene
expression. Cancer Cell. 13:496–506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sato F, Tsuchiya S, Meltzer SJ and Shimizu
K: MicroRNAs and epigenetics. FEBS J. 278:1598–1609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
